Tag

Medical Ethics

All articles tagged with #medical ethics

Shanghai Disciplines Scientists After Child Dies in Unreported Gene-Editing Trial
science-and-health44 minutes ago

Shanghai Disciplines Scientists After Child Dies in Unreported Gene-Editing Trial

Chinese authorities dismissed two researchers and disciplined others after an investigation found that an experimental gene-editing trial at Shanghai Jiao Tong University led to the death of a six-year-old girl. The study, which targeted a rare neurodevelopmental disorder, lacked public registration and independent safety oversight. While the trial was approved by a hospital ethics committee in January 2025, investigators found that safety warnings from animal testing were ignored, and the child’s death was not disclosed when the team published their findings in February 2026. The case highlights gaps in China’s regulatory framework for investigator-initiated trials, prompting new inspections of biomedical research.

Laura Sides’ Decision to Test for Hereditary Dementia Reshapes Her Life
health8 days ago

Laura Sides’ Decision to Test for Hereditary Dementia Reshapes Her Life

Laura Sides, now 43, underwent genetic testing in her 30s after her father died of the 'London variant' of early-onset Alzheimer's. The test confirmed she inherited the gene, with symptoms predicted to begin between ages 46 and 48. This knowledge has fundamentally altered her life choices, including her decision not to have children and her focus on immediate joys rather than long-term aspirations.

28% of US Adults Fabricate Symptoms to Secure Antibiotics, Study Finds
health11 days ago

28% of US Adults Fabricate Symptoms to Secure Antibiotics, Study Finds

A new study in JAMA Network Open reveals that 28% of US adults and 27% of caregivers have lied to doctors to obtain antibiotics. Most fabricate symptoms of viral illnesses, like colds, which antibiotics do not treat. Despite this, 77% of adults and 87% of caregivers successfully received prescriptions. Researchers warn this drives antibiotic resistance and harms patient trust, urging better communication rather than suspicion.

STAT Investigation Exposes Exploitative 'Three-Parent IVF' Tourism for Older Women
health-and-science11 days ago

STAT Investigation Exposes Exploitative 'Three-Parent IVF' Tourism for Older Women

A STAT investigation reveals that 'three-parent IVF' (MRT), a technique originally designed to prevent fatal mitochondrial diseases, is being commercially marketed to older women in the U.S. and Europe despite lacking scientific evidence for efficacy. An Illinois-based facilitator, International Fertility Group (IFG), connects patients with clinics in Albania, Ukraine, and elsewhere, charging tens of thousands of dollars for a procedure that experts say fails for most women over 40. While IFG claims high success rates, independent data suggests these figures are misleading or unsubstantiated. The practice remains illegal in the U.S. due to congressional bans, leading to a shadow industry of medical tourism. Critics warn that patients are being financially exploited and subjected to unproven medical experiments, while proponents argue it offers a last resort for those with advanced maternal age.

New Study: 28% of US Adults Lie to Doctors for Antibiotics, Often Successfully
health14 days ago

New Study: 28% of US Adults Lie to Doctors for Antibiotics, Often Successfully

Two new studies published in JAMA Network Open reveal that 28% of US adults and 27% of caregivers have lied to clinicians to obtain antibiotics. Patients frequently exaggerate or fabricate viral symptoms, such as colds, which antibiotics do not treat. Despite the medical inappropriateness, 77% of adults and 87% of caregivers reported success in obtaining prescriptions. Researchers emphasize that this behavior stems from a lack of trust and a desire for control, highlighting the need for better patient-clinician communication rather than increased suspicion.

health15 days ago

Medical Professionals Share Vulnerability and Systemic Frustrations After Becoming Patients in Their Own Specialties

A compilation of 22 anecdotes from medical professionals reveals the stark contrast between their clinical expertise and their experiences as patients. While some found comfort in familiar environments, others faced significant vulnerability, systemic barriers, and emotional distress. These stories highlight how becoming a patient often humbles practitioners, forcing them to confront the inadequacies of the healthcare system they navigate daily. The accounts emphasize that even with deep medical knowledge, doctors struggle with advocacy, fear, and the emotional toll of treatment, ultimately fostering greater empathy for their patients.

Dr. Roach Advises 85-Year-Old With Positive Cologuard to Weigh Colonoscopy Risks Against Cancer Probability
health15 days ago

Dr. Roach Advises 85-Year-Old With Positive Cologuard to Weigh Colonoscopy Risks Against Cancer Probability

An 85-year-old woman with a positive Cologuard test and recent sarcoma history seeks guidance on next steps after her gastroenterologist declined a colonoscopy. Dr. Mehmet Oz, writing as Dr. Roach, notes that a positive Cologuard result implies a 38% risk of advanced polyps and a 4% risk of colon cancer. He advises that while virtual CT colonography is an alternative, it may not resolve diagnostic uncertainty. If the patient is willing to undergo surgery for potential cancer, a colonoscopy remains the gold standard despite a 1% complication risk, which is lower than the cancer risk. He suggests seeking a second opinion if the current doctor refuses to proceed.

Dr. Rachna Shroff, 47, Dies of Aggressive Cancer After Endowing $1.35M Award
health-and-science27 days ago

Dr. Rachna Shroff, 47, Dies of Aggressive Cancer After Endowing $1.35M Award

Dr. Rachna Shroff, a prominent gastrointestinal oncologist and researcher at the University of Arizona, has died at age 47 from an aggressive cancer she had spent her career studying. Shroff, who served as associate director of clinical investigations at the U of A Cancer Center, was diagnosed in May 2026 with terminal adenocarcinoma after noticing a swollen lymph node. Despite her rapid decline, she continued working, attending major conferences, and successfully raised over $1.35 million to establish the Conquer Cancer – Rachna Shroff Endowed Young Investigator Award in Biliary Cancers. Her death highlights the urgent need for funding in under-researched areas like cholangiocarcinoma, a field where her clinical trials helped shift treatment standards. Colleagues and family remember her as a tireless mentor and compassionate clinician who prioritized patient care and scientific rigor.

GLP-1 Users Face Dual Stigma, Leading to Hidden Treatment and Altered Medical Choices
health-and-society28 days ago

GLP-1 Users Face Dual Stigma, Leading to Hidden Treatment and Altered Medical Choices

A new study reveals that individuals taking GLP-1 medications face a 'double stigma' for their body size and their choice of medical treatment. This social pressure leads many patients to hide their medication use, alter dosing without supervision, or seek alternative providers to avoid judgment. Clinicians are urged to use empathetic, open-ended communication to counteract these barriers and ensure patients feel safe discussing their health goals.

Dr. Rachna Shroff, 47, Dies of Aggressive GI Cancer After Final Push to Fund Biliary Research
health29 days ago

Dr. Rachna Shroff, 47, Dies of Aggressive GI Cancer After Final Push to Fund Biliary Research

Dr. Rachna Shroff, a prominent gastrointestinal cancer researcher at the University of Arizona, has died at age 47 from the aggressive disease she dedicated her career to treating. Diagnosed in May 2026 with terminal adenocarcinoma, she continued working until her death, recently securing $1.35 million to endow a permanent award for young biliary cancer investigators. Her legacy includes landmark clinical trials that transformed treatment options for rare bile duct cancers.

Surgeon’s Retirement After Neurological Decline Sparks Debate Over Mandatory Physician Screening
health1 month ago

Surgeon’s Retirement After Neurological Decline Sparks Debate Over Mandatory Physician Screening

A high-profile lawsuit against a Florida orthopedic surgeon who operated while suffering from a progressive neurological condition has intensified the debate over how to assess the fitness of aging physicians. While some advocate for mandatory cognitive testing, medical professionals resist such measures, citing privacy concerns and the lack of reliable screening tools. The case highlights a growing gap between the aging doctor workforce and current regulatory frameworks, prompting calls for career-long competency assessments rather than age-based mandates.

Cochrane Review Links Pharma Free Meals to Increased Prescribing
health1 month ago

Cochrane Review Links Pharma Free Meals to Increased Prescribing

A new Cochrane systematic review confirms that free meals and gifts from pharmaceutical companies significantly influence doctor prescribing habits. Analyzing 93 studies, the research found a direct correlation between the volume of promotional perks received and the frequency of prescriptions for specific drugs, including opioids. While doctors often dismiss these incentives as trivial, the data shows they lead to less appropriate and more expensive treatments. The review also indicates that strict conflict-of-interest policies can mitigate these effects, though the impact on overall healthcare costs remains uncertain.

US Surgeons Begin First Robotic Trials for Controversial Alzheimer's Lymphatic Procedure
health1 month ago

US Surgeons Begin First Robotic Trials for Controversial Alzheimer's Lymphatic Procedure

Scientists in the US and Europe are launching rigorous trials to test if a controversial neck surgery can treat Alzheimer's disease. The procedure, which connects lymph nodes to veins to drain brain waste, has faced scrutiny in China due to unverified claims and regulatory crackdowns. US researchers aim to determine if the method is a genuine breakthrough or a false hope through controlled studies.

Prestigious US Hospitals Launch High-Cost Longevity Clinics Amid Scientific Debate
health1 month ago

Prestigious US Hospitals Launch High-Cost Longevity Clinics Amid Scientific Debate

Major nonprofit health systems including Northwestern Medicine, Weill Cornell, and Mayo Clinic have launched cash-pay longevity clinics offering comprehensive assessments for approximately $5,500 annually. These programs aim to provide detailed data on aging trajectories and physical fitness, moving beyond standard primary care. While proponents argue this offers a rigorous scientific approach to preserving healthspan, critics question the alignment of high out-of-pocket costs with nonprofit charitable missions and warn that many offered tests lack sufficient evidence to prove they improve health outcomes.